Clinical Trial Update: Fenretinide in Treating Patients Who Have Undergone Surgery for Bladder Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for fenretinide in bladder cancer patients after surgery has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• Fenretinide (fenretinide)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Bladder Cancer | Phase 3 | Status: COMPLETED